These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25693891)

  • 1. Hyperfibrinolysis during liver transplantation is associated with bleeding.
    Roullet S; Freyburger G; Labrouche S; Morisse E; Stecken L; Quinart A; Laurent C; Sztark F
    Thromb Haemost; 2015 May; 113(5):1145-8. PubMed ID: 25693891
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperfibrinolysis in liver disease.
    Ferro D; Celestini A; Violi F
    Clin Liver Dis; 2009 Feb; 13(1):21-31. PubMed ID: 19150306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A kinetic model of the circulatory regulation of tissue plasminogen activator during orthotopic liver transplantation.
    Crookston KP; Marsh CL; Chandler WL
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):79-88. PubMed ID: 10691102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Massive bleeding due to hyperfibrinolysis during living-related liver transplantation for terminal liver cirrhosis; report of two cases].
    Kaku R; Matsumi M; Ichiyama M; Kajihara H; Fujii H; Ohashi I; Mizobuchi S; Morita K
    Masui; 2003 Nov; 52(11):1195-9. PubMed ID: 14661565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients.
    Cardenas JC; Matijevic N; Baer LA; Holcomb JB; Cotton BA; Wade CE
    Shock; 2014 Jun; 41(6):514-21. PubMed ID: 24667610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aprotinin inhibits tissue plasminogen activator-mediated fibrinolysis during orthotopic liver transplantation.
    Cottam S; Hunt B; Segal H; Ginsburg R; Potter D
    Transplant Proc; 1991 Jun; 23(3):1933. PubMed ID: 1712135
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group.
    Violl F; Basili S; Ferro D; Quintarelli C; Alessandril C; Cordova C
    Thromb Haemost; 1996 Aug; 76(2):177-83. PubMed ID: 8865526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection.
    Tsuji K; Eguchi Y; Kodama M
    J Am Coll Surg; 1996 Sep; 183(3):230-8. PubMed ID: 8784316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA) in orthotopic liver transplantation (OLT).
    Himmelreich G; Dooijewaard G; Breinl P; Bechstein WO; Neuhaus P; Kluft C; Riess H
    Thromb Haemost; 1993 Jan; 69(1):56-9. PubMed ID: 8446939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cause of hematic cysts of the orbit: increased fibrinolysis and immunohistologic expression of tissue plasminogen activator.
    Yoshikawa K; Fujisawa H; Kajiwara K; Fujii M; Kato S; Akimura T; Nomura S; Gondo T; Suzuki M
    Ophthalmology; 2009 Jan; 116(1):130-4. PubMed ID: 19019445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired capacity for endogenous fibrinolysis in essential hypertension.
    Hrafnkelsdóttir T; Wall U; Jern C; Jern S
    Lancet; 1998 Nov; 352(9140):1597-8. PubMed ID: 9843110
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
    Moniwa N
    Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of peritoneal fibrinolysis owing to decreased transcription of plasminogen activator inhibitor-1 in peritoneal mesothelial cells suppresses postoperative adhesion formation in laparoscopic surgery.
    Shimomura M; Hinoi T; Ikeda S; Adachi T; Kawaguchi Y; Tokunaga M; Sasada T; Egi H; Tanabe K; Okajima M; Ohdan H
    Surgery; 2013 Mar; 153(3):344-56. PubMed ID: 23218127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early thrombin generation and impaired fibrinolysis after SCT associate with acute GVHD.
    Pinomäki A; Volin L; Joutsi-Korhonen L; Virtanen JO; Lemponen M; Ruutu T; Lassila R
    Bone Marrow Transplant; 2010 Apr; 45(4):730-7. PubMed ID: 19718071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic changes and the influence of the early perfusate in orthotopic liver transplantation with intraoperative aprotinin treatment.
    Himmelreich G; Kierzek B; Neuhaus P; Slamer KJ; Riess H
    Transplant Proc; 1991 Jun; 23(3):1936-7. PubMed ID: 1712137
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal massive infectious gas gangrene in a liver transplant recipient.
    Levi Sandri GB; Rayar M; Sulpice L; Houssel-Debry P; Boudjema K
    Liver Transpl; 2014 Apr; 20(4):493-4. PubMed ID: 24415557
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors for kidney impairment and differential impact of liver transplantation on renal function.
    Sezer S; Karakan S; Erişmiş B; Çolak T; Haberal M
    Transplant Proc; 2011 Mar; 43(2):609-11. PubMed ID: 21440776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.
    Violi F; Ferro D; Basili S; Quintarelli C; Musca A; Cordova C; Balsano F
    Hepatology; 1993 Jan; 17(1):78-83. PubMed ID: 8423044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolytic abnormalities following liver transplantation in patients with fulminant hepatic failure.
    Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):155-9. PubMed ID: 7536112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.